Trial Profile
Randomized Double-Blind, Placebo-Controlled Parallel Multi-Center Study to Assess the Efficacy of Cannabidiol (BRCX014) Combined With Standard-Of-Care Treatment in Subjects With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 22 Dec 2020
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary) ; Bevacizumab; Bortezomib; Fluorouracil; Folinic acid; Gemcitabine; Irinotecan; Oxaliplatin; Temozolomide
- Indications Colorectal cancer; Gastrointestinal cancer; Glioblastoma; Multiple myeloma; Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Leaf Vertical
- 07 Aug 2018 New trial record